suMMARY The right ventricular repolarisation phase was studied electrophysiologically after an injection of 15 mg metoprolol in 16 healthy volunteers. Eight of them were restudied after chronic treatment with 400 mg metoprolol daily for five weeks. The assessment of the repolarisation time included ventricular effective refractory periods, monophasic action potential duration, and the QT interval measured during atrial stimulation at different driving frequencies. The acute administration of 15 mg metoprolol intravenously had no detectable effect on the repolarisation phase, while chronic treatment caused a significant increase of the ventricular effective refractory periods, monophasic action potential duration, and the QT interval during atrial stimulation. Thus the study confirmed the contrasting effect of acute and chronic beta-receptor blockade on the ventricular repolarisation time in man.
In the classification of antiarrhythmic drugs proposed by Vaughan Williams,' class II was reserved for the sympathicolytic agents. By interfering with the effects of catecholamines, betaadrenergic blocking drugs reduce in vitro the slope of the phase 4 depolarisation of pacemaker cells within the sinus node, atria, atrioventricular node, and Purkinje fibres.
The effects on atrial muscle cells, Purkinje fibres, and ventricular muscle cells are generally small except in conditions with a high degree of sympathetic stimulation.2 Beta-adrenergic receptor blocking drugs cause a decrease in the conduction velocity within the atria, atrioventricular node, Purkinje fibres, and ventricular myocardial cells, while there is little or no influence on the repolarisation time after acute administration. 3 4 Some beta-adrenergic receptor antagonists, such as propranolol and alprenolol, also have a direct membrane-stabilising action, leading to delay of the depolarisation phase. This class I effect' is a pharmacological phenomenon seen in vitro at high concentrations and is not likely to be of any antiarrhythmic importance with therapeutic betablocking doses in a normally oxygenated muscle. [5] [6] [7] Furthermore, recent studies in vitro on rabbit hearts showed that chronic beta-receptor blockade *This study was supported by grants from the Medical Society of G6teborg and The National Society Against Heart and Chest Diseases.
Received for publication 31 July 1980   628 with propranolol, acebutolol, and practolol produced a slowly developing prolongation of the repolarisation time in both atria and ventricles. After two weeks a plateau level was reached and was sustained throughout the six-week period of treatment and for about two weeks after its discontinuation.8 9 This study was designed to determine whether a similar effect is obtained after chronic beta-receptor blockade in man, using the method of monophasic action potential recording.
Subjects and methods
Sixteen healthy young volunteers, all men (mean age 30 years, range 20 to 35 years) underwent an electrophysiological investigation and eight of them were also subjected to a second identical investigation after five weeks of oral beta-blockade (Fig 1) .
The study was approved by the ethical committee of the University of Goteborg. Informed consent was obtained from each volunteer. None of them were taking any drugs at the time of the study.
Before the invasive part of the study a routine investigation was performed, including a medical history and a physical examination, laboratory tests, and a 12-lead electrocardiogram. All volunteers also had a chest x-ray film.
where atrial stimulation for QT interval studies was performed laterally in the vicinity of the sinuatrial node. The catheter was then repositioned for recording of the His bundle electrogram and then into a stable position at the right ventricular apex.
A bipolar suction electrode catheter for recording of monophasic action potential signals was then also introduced percutaneously via the right femoral vein and placed across the tricuspid valve in a nonarrhythmogenic position.
The ventricular effective refractory period was determined through the pacemaker electrode at thfe apex, and the suction electrode catheter tip was then carefully placed perpendicular to the endocardial wall in the outflow tract, and suction ( -350 mmHg) was applied. A simultaneously recorded normal right ventricular electrogram was required for the monophasic action potential signal to be accepted.
After the signals had been recorded the ventricular effective refractory period was determined by stimulating through the suction electrode catheter during maintenance of suction. Thus, the position was identical to that from which the monophasic action potential signals had been obtained. Care was taken not to exceed a continuous suction time of two minutes.
When these measurements were concluded, 15 mg metoprolol was given intravenously over a period of five minutes. Blood pressure and heart rate were checked before, during, and after the injection at two-minute intervals. Ten minutes after the end of the injection all measurements were repeated in the reverse order.
Great care was taken to keep the pacemaker electrode in an unchanged position during all measurements and the monophasic action potential catheter in a fluoroscopically identical position, though suction had to be released between the recordings.
Blood samples for analysis of the concentration of metoprolol in plasma were collected immediately before and 10 minutes after the injection. After oral treatment no detectable amounts of the drug are found in plasma about 40 hours after it has been withdrawn. 16 In this study, the acute administration of metoprolol had no significant effect on the electrophysiological variables measured from the right ventricle. As expected, heart rate decreased significantly. This is in agreement with the acute electrophysiological effects of other beta-adrenergic blocking agents. During chronic treatment a decrease in heart rate was also seen, reflecting the adaptational bradycardia. Thus, the mean fall in heart rate was seven beats per minute (10%), though healthy young men might not be expected to have much background sympathetic drive. On the other hand, the intravenous dose after chronic treatment produced a further decrease of the heart rate by five beats per minute (8%). Actually, the mean heart rate was almost the same (58 and 56 beats per minute) after acute metoprolol both before and after adaptation, reflecting less response to acute beta-blockade after the adaptation, the mean fall in heart rate being five instead of 10 22 Among the different components in the specialised conduction system of the heart, the Purkinje fibre cells show the longest repolarisation time under normal conditions. The increase in repolarisation time induced by amiodarone, however, has been shown to affect the atrial and ventricular muscle cells to a greater extent than the Purkinje fibre cells. 23 It would be reasonable to assume that the increase found after chronic treatment with metoprolol using the monophasic action potential technique would also reflect changes in ventricular muscle cell repolarisation rather than in the Purkinje fibre cells, since the monophasic action potential signal consists of signals from a number of cells at the endocardial surface, where the probability of picking up selective signals from the specialised conduction system seems negligible.
The beta-blocker sotalol, long known to cause arn increase in action potential duration after acute administration to guinea-pigs in vitro,17 was recently shown to produce an average increase in the right ventricular monophasic action potential duration of 42 ms (17%) in eight patients with chronic atrial fibrillation receiving a maximum dose of 100 mg intravenously. 24 This class III mode of action developing during chronic beta-receptor blockade was first shown in rabbit hearts in vitro using a microelectrode technique.8 9 25 The action potentials of both atria and ventricles increased in duration, especially at the end of the repolarisation. The same phenomenon was seen in vivo in rabbits25 and in studies in man with QT measurement and QTc calculation. 26 In these studies different beta-blocking agents, both with and without cardioselectivity and intrinsic stimulating activity, were used. This suggests that the increase in repolarisation time may be a general property of beta-blockers, regardless of their pharmacological differences.
The effect of chronic beta-receptor blockade upon ventricular repolarisation is in strong contrast to the lack of influence on ventricular repolarisation which characterises acute beta-blockade, the only exception being sotalol, which has a pronounced class III action after acute administration in animal experiments in vitro1718 and in man. 24 The subtle changes of the ventricular repolarisation that we have noted are within the range of inter-individual differences noted in a population of healthy subjects. 26 The possible connection between changes in ventricular repolarisation and the antiarrhythmic effects of chronic beta-receptor blockade must be made with great caution. For instance, it must still be considered an open question whether the lower mortality in patients who are treated with beta-blockers after acute myocardial infarction27 28 can be related to a decreased susceptibility to life-threatening ventricular arrhythmias on the basis of this very moderate prolongation of the ventricular repolarisation, a mechanism that has been suggested. 
